Others involve the use of synthetic peptides derived from the p53 C-terminus with the aim of restoring the specific DNA binding and transactivation function to mutant p53 and inducing p53-dependent apoptosis in tumor cells [9,10]. The gene discussed is TP53; the disease is neoplasm.